Consistently, reduced NLRP3-dependent IL-1β secretion is observed in AMs isolated from the bronchoalveolar lavage of lung cancer patients despite a systemic higher NLRP3 inflammasome activation and IL-1β secretion in peripheral blood leukocytes from these patients [230,231]. The gene discussed is NLRP3; the disease is lung carcinoma.